These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 2495588

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
    Grazia TJ, Gill RG, Gelhaus HC, Doan AN, Sleater ML, Pietra BA.
    J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
    Chavin KD, Qin L, Lin J, Yagita H, Bromberg JS.
    J Immunol; 1993 Dec 15; 151(12):7249-59. PubMed ID: 7903105
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Deletion of graft reactive cells by idarubicin-anti-CD8 (Ly-2.1) immunoconjugate: studies in the mouse heart graft model.
    Mottram PL, Pietersz GA, Purcell LJ, Krauer K, Clunie GJ, McKenzie IF.
    Transplant Proc; 1991 Feb 15; 23(1 Pt 1):499-500. PubMed ID: 1899311
    [No Abstract] [Full Text] [Related]

  • 13. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR, Zhan Y, Murray-Segal LJ, Brady JL, Lew AM, Mottram PL.
    Transplantation; 2000 Jul 15; 70(1):168-74. PubMed ID: 10919596
    [Abstract] [Full Text] [Related]

  • 14. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4.
    Jendrisak M, Jendrisak G, Gamero J, Mohanakumar T.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 1):825-7. PubMed ID: 8094914
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The synergistic effect of anti-CD4 monoclonal antibodies and cyclosporin A on murine fetal islet allograft survival.
    Burkhardt K, Charlton B, Mandel TE.
    Transplant Proc; 1989 Feb 15; 21(1 Pt 3):2663-4. PubMed ID: 2495663
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prolonged survival of mouse cardiac allografts after CD4 or CD8 monoclonal antibody therapy is associated with selective intragraft cytokine protein expression: interleukin (IL)-4 and IL-10 but not IL-2 or interferon-gamma.
    Hancock W, Mottram PL, Purcell LJ, Han WR, Pietersz GA, McKenzie IF.
    Transplant Proc; 1993 Oct 15; 25(5):2937-8. PubMed ID: 8212290
    [No Abstract] [Full Text] [Related]

  • 20. Effects of anti-L3T4 and anti-Lyt 2 monoclonal antibodies on murine cardiac allograft rejection.
    Madsen JC, Wood KJ, Morris PJ.
    Transplant Proc; 1987 Oct 15; 19(5):3991-2. PubMed ID: 3313979
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.